We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$41.7B
AUM Growth
+$2.19B
Cap. Flow
+$590M
Cap. Flow %
1.42%
Top 10 Hldgs %
9.51%
Holding
3,328
New
131
Increased
1,345
Reduced
1,491
Closed
336
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDTI
2276
DELISTED
Integrated Device Technology I
IDTI
$916K ﹤0.01%
57,411
+26,967
+89% +$419K
ICMB icon
2277
Investcorp Credit Management BDC
ICMB
$12.1M
$915K ﹤0.01%
69,700
-77,945
-53% -$1.07M
CLW icon
2278
Clearwater Paper
CLW
$376M
$914K ﹤0.01%
15,210
-421
-3% -$27.8K
TMH
2279
DELISTED
Team Health Holdings Inc
TMH
$914K ﹤0.01%
15,764
-356
-2% -$19.9K
MTN icon
2280
CALL
Vail Resorts
MTN
$5.3B
$911K ﹤0.01%
+10,500
New +$834K
VSI
2281
DELISTED
Vitamin Shoppe Inc.
VSI
$908K ﹤0.01%
20,451
-49,163
-71% -$2.06M
ASTE icon
2282
Astec Industries
ASTE
$1.02B
$907K ﹤0.01%
24,862
-601
-2% -$24.4K
NEU icon
2283
NewMarket
NEU
$8.18B
$907K ﹤0.01%
2,381
-349
-13% -$138K
TYL icon
2284
Tyler Technologies
TYL
$12.8B
$906K ﹤0.01%
10,244
-1,132
-10% -$102K
AUXL
2285
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$904K ﹤0.01%
30,261
+4,520
+18% +$95.8K
AKO.B icon
2286
Embotelladora Andina Series B
AKO.B
$4.95B
$902K ﹤0.01%
47,074
-10,567
-18% -$217K
UHAL icon
2287
U-Haul Holding Co
UHAL
$14.6B
$901K ﹤0.01%
34,390
-1,440
-4% -$39.8K
MNP
2288
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$898K ﹤0.01%
60,461
-5,400
-8% -$80.2K
VEDL
2289
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$893K ﹤0.01%
51,694
-5,915
-10% -$112K
AVTA
2290
DELISTED
Avantax, Inc. Common Stock
AVTA
$888K ﹤0.01%
58,250
-10,494
-15% -$173K
ANK
2291
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
$887K ﹤0.01%
16,453
+270
+2% +$14.6K
CNQ icon
2292
Canadian Natural Resources
CNQ
$94.9B
$885K ﹤0.01%
47,099
-15,232
-24% -$314K
FULT icon
2293
Fulton Financial
FULT
$4.64B
$884K ﹤0.01%
79,790
+158
+0.2% +$1.83K
GLP icon
2294
Global Partners
GLP
$1.7B
$883K ﹤0.01%
21,210
-1,597
-7% -$66.8K
WGO icon
2295
Winnebago Industries
WGO
$909M
$879K ﹤0.01%
40,402
-2,565
-6% -$62.7K
RSX
2296
DELISTED
VanEck Russia ETF
RSX
$879K ﹤0.01%
39,160
-6,127
-14% -$152K
GIL icon
2297
Gildan
GIL
$10.6B
$877K ﹤0.01%
+32,050
New +$926K
RDY icon
2298
Dr. Reddy's Laboratories
RDY
$10.2B
$876K ﹤0.01%
83,360
-4,795
-5% -$45.1K
CULP icon
2299
Culp Inc
CULP
$44.1M
$875K ﹤0.01%
48,209
-28,384
-37% -$507K
BGG
2300
DELISTED
Briggs & Stratton Corp.
BGG
$872K ﹤0.01%
48,400
-1,216
-2% -$23.8K

Similar funds

Guggenheim Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Guggenheim Capital held 3,328 positions worth $41.7B, up 5.5% from $39.5B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Guggenheim Capital's Q3 2014 filing shows 131 new, 1,345 increased, 1,491 reduced and 336 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M. The largest sale was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, an estimated $98.4M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Guggenheim Capital's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M.
  • Guggenheim Capital added most to CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q3 2014, an estimated $96.3M increase.
  • Guggenheim Capital's biggest Q3 2014 reduction was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $98.4M.
  • Guggenheim Capital fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $40.1M.
  • Guggenheim Capital's ten largest holdings make up 9.5% of its $41.7B portfolio in Q3 2014.
  • Guggenheim Capital opened 131 new positions and closed 336 in Q3 2014.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $41.7B.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.